- Entry
- $3.15
- Now
- $1.65 -47.7%
- Target
- $15.00
- Score
- —
A few facts that are difficult to ignore right now: • CVRx reported **$15.7M in Q2 2026 revenue**, up 16% YoY, with an **87% gross margin**. U.S. revenue grew 21%. • In May, **Humana** introduced Medicare Advantage coverage for Barostim. Today, CVRx announced that **Devoted Health** also issued a coverage policy, effective July 17, 2026. Together, Humana and Devoted represent approximately **21% of Medicare Advantage enrollment**. Devoted covers approximately **466,000 members across 29 states**, including patients enrolled in BENEFIT-HF. • …
— ORIGINAL POST ·
🎩✅CVRX - The strategic value of Barostim could be significantly higher than the current valuation
· r/pennystocks
· Aug 24, 2026